Autopsy report · NCT00242827
Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma
Cause of deathNo reason given
Life of this trial
- Registered 7 months before it started.
- Ran for about 1 year 1 month before it stopped.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Cephalon
- Sponsor type
- Industry
- Conditions
- Myeloma
- Interventions
- Oral CEP-701
- Sites
- 5
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.